Our Staff Writers and Editors offer insights on the latest news, events, interviews and other happenings from the development through enterprise and base of the pyramid universes
Friday, October 2, 2015 — No Region Specified

‘Egg’ Nobel Winner Cracks Global Anaesthetic

Source: InDaily

One of the world’s most in-demand anaesthetics can now be produced on the spot, thanks to the thermos-flask sized device that recently won Flinders University inventor Professor Colin Raston an Ig Nobel prize.
Thursday, September 24, 2015 — South Asia

Asia's Biggest Vaccine Maker to Seek Fast-Track Nod for Dengue Drug in India

Source: Fox News

Asia's largest vaccine maker, Serum Institute of India, plans to file for fast-track approval to launch a dengue treatment in India, its chief executive said, potentially becoming the first company globally to launch a drug for the mosquito-borne virus.
Wednesday, September 23, 2015 — No Region Specified

Martin Shkreli Announces Turnaround on 5,000% Price Rise for Drug

Source: The Guardian

Turing Pharmaceuticals, a small company that generated outrage by raising the cost of an old anti-infective drug by more than 5,000%, said it would roll back that increase to make sure it remains affordable.
Tuesday, September 22, 2015 — No Region Specified

Regeneron Announces Agreement with BARDA for the Development of New Antibody Treatment for Ebola

Source: Press Release

Regeneron Pharmaceuticals, Inc.REGN, -1.42% today announced an agreement with the Biomedical Advanced Research and Development Authority (BARDA) of the U.S. Department of Health and Human Services (HHS) to develop, test and manufacture a monoclonal antibody therapy for the treatment of Ebola virus infection.
Friday, September 11, 2015 — Sub-Saharan Africa

Ebola's 'magic pill' might actually be a machine

Source: Fortune

Early intervention with medical devices focused on “simple things” could be better than drugs at halting infectious disease outbreaks.
Tuesday, September 8, 2015 — No Region Specified

5 dengue vaccines in development

Source: Infectious Disease News

Currently, there are no approved vaccines or therapies to prevent dengue infection. The disease, which primarily affects children, is associated with approximately 22,000 deaths annually worldwide, according to the CDC. Infectious Disease News has compiled information on five candidate dengue vaccines in various stages of development.
Monday, August 31, 2015 — South Asia

Focus on Private Sector: India’s generic drug wars

Source: SciDevNet

India makes lifesaving medicine that Africa can afford — and U.S. pressure mustn’t cripple that, says Maha Rafi Atal.
Wednesday, August 26, 2015 — South Asia

Health ministry against task force proposal to hike prices of vital drugs

Source: The Times of India

A government task force has recommended changes in the existing drug price regulation which could result in a spike in prices of essential medicines. These include suggestions to pull several medicines out of price control, which is likely to impact drugs used in treatment of diabetes, cancer and cardiovascular diseases as well as antibiotics.
Monday, August 17, 2015 — No Region Specified

Viewpoint: TPP's Outcome Pivotal for Future of Global Biomedical Innovation

Source: The Hill

After seven years of wrangling toward the final terms of an ambitious free trade agreement that will join 12 Asia-Pacific nations, only the thorniest of market access and intellectual property issues remain unresolved in the Trans-Pacific Partnership (TPP). Of these, perhaps the most contentious concerns how long pharmaceutical companies should have exclusive intellectual property rights covering the clinical trial data they compile as they develop novel biologic medicines. U.S. negotiators have stood fast in advocating for 12 years of data protection — the standard that Congress enshrined into U.S. law following extensive deliberation — while other TPP parties have sought to limit the regulatory data protection period to as little as five to seven years.
Friday, August 14, 2015 — No Region Specified

Why drug companies are betting big on 'pharmerging' countries

Source: Fortune

Developing countries like China, Brazil and India will drive nearly half of the growth in drug spending in the near future. Here’s how Big Pharma could play the trend.
Tuesday, August 11, 2015 — Sub-Saharan Africa

One Man's Quest to Combat Counterfeit Drugs — With a Suitcase

Source: NPR

In a small house in rural Kenya, a young woman gives birth to a healthy little girl. Before anyone can celebrate, the mother starts bleeding. The woman will die soon if the bleeding doesn't stop.
Monday, August 10, 2015 — Sub-Saharan Africa

Why South Africa's Health Minister Is So Worried About India Caving in to Big Pharma


A big supplier of cheap lifesaving drugs to developing nations, India admirably balances public health needs with private profits and innovation. But it is under pressure to change this model.
Thursday, August 6, 2015 — Sub-Saharan Africa

OPINION: What ‘100 Percent Effective’ Means for That Ebola Vaccine

Source: Wired

Lat week, the medical journal the Lancet published preliminary results on the efficacy of an Ebola vaccine in Guinea, and everybody got really excited – especially about one particular figure. The vaccine, the results suggested, was 100 percent effective at protecting against Ebola ... But that number probably means less than you think it does.
Tuesday, August 4, 2015 — Sub-Saharan Africa

The African Startup Using Phones to Spot Counterfeit Drugs

Source: Bloomberg Business

A Ghanaian entrepreneur thinks he has the answer to Africa’s fake medicine problem.
Tuesday, August 4, 2015 — No Region Specified

Global Vaccine-Development Fund Could Save Thousands of Lives, Billions of Dollars

Source: EurekAlert!

Ebola is a preventable disease, and yet a safe and effective vaccine has not been deployed. As with many vaccines, financial barriers persist: pharmaceutical companies see high costs with limited market potential, and government support is lacking. But there may be a solution to this vaccine crisis with the ability to save at-risk populations, according to a perspective piece written by physicians based at Princeton University, University of Pennsylvania and the Wellcome Trust.
Tuesday, August 4, 2015 — Sub-Saharan Africa

Viewpoint: Ebola Vaccine: The Need to Act Now

Source: The New York Times

One year ago West Africa was descending into chaos. As the Ebola death toll approached 1,000 for the first time ever and Liberia closed its borders, the World Health Organization declared the situation an international health emergency. Experimental drugs were cautiously put to use to try to treat those infected, but what was urgently needed to stop the spread was a vaccine. Now, 12 months on, it looks very much like we have one.
Friday, July 31, 2015 — No Region Specified

Patent Protection for Drugs Puts Pressure on U.S. in Trade Talks

Source: The New York Times

With 12 nations pressing to conclude the largest regional trade accord ever, United States officials find themselves squeezed between activists pressing to secure access to low-cost pharmaceuticals and Republicans who say Congress will reject a deal without strong patent protections for the drug industry.
Friday, July 31, 2015 — Sub-Saharan Africa

GlaxoSmithKline Sees Staged Roll-Out of Malaria Vaccine

Source: Reuters

The world's first malaria vaccine, which won a green light last week from European drugs regulators, will be rolled out gradually in Africa, its maker said on Wednesday.
Friday, July 24, 2015 — South Asia

India's 'Medicine Baba' Gets Drugs From Rich, Gives to Poor

Source: ABC News

Omkarnath spends his days searching New Delhi for drugs. A call to the phone number printed boldly on his saffron-colored tunic reveals his alternate identity: "Hello, I am Medicine Baba."
Friday, July 24, 2015 — No Region Specified

World's First Malaria Vaccine Gets Regulatory Go-Ahead, Faces WHO Review

Source: Reuters

The world's first malaria vaccine got a green light on Friday from European drugs regulators who recommended it as safe and effective to use in babies in Africa at risk of the mosquito-borne disease.
Thursday, July 23, 2015 — No Region Specified

Health Specialists Call for $2 Billion Global Fund for Vaccines

Source: Reuters

Global health experts called on Wednesday for the creation of a $2 billion vaccine development fund to feed a pipeline of potential new shots against priority killer diseases like Ebola, MERS and the West Nile virus.
Wednesday, July 22, 2015 — South Asia

Viewpoint: India Must Keep Patent Laws for Manufacture of Cheap Generic Drugs

Source: Hindustan Times

Recently, trade ministers from 10 Asean countries, India, China, Japan, Australia, New Zealand and South Korea gathered to negotiate a deal on the Regional Comprehensive Economic Partnership (RCEP) trade agreement. But, RCEP negotiations on intellectual property (IP) are at a standstill because India and the Asean countries are unwilling to trade away health by adopting IP provisions that go beyond what is required of them under international trade rules.
Wednesday, July 22, 2015 — No Region Specified

Are Pharma Giants Living Up to Big Promises on Development?

Source: The Guardian

he pharmaceutical industry plays a fundamental role in achieving international development targets. This was recognised in the millennium development goals (MDGs), which explicitly mention that providing access to affordable essential drugs in low- and middle-income countries has to be achieved “in cooperation with pharmaceutical companies”. Yet efforts to track progress towards the MDGs have focused mainly on government action rather than corporate contributions.
Tuesday, July 21, 2015 — No Region Specified

Sanofi Preps for 'Profitable' Dengue Vaccine Rollout in 20 Countries

Source: FiercePharma

With more than $1.5 billion in development costs and 20 years of research on the line, Sanofi ($SNY) is getting revved up to launch its world-first dengue vaccine later this year. And if the company's predictions are correct, the shot will not only be a big deal for patients in the developing world--it'll be a highly profitable product to boot.
Friday, July 17, 2015 — North Africa and Near East

Iran Nuclear Deal: Lifting Sanctions Could Transform Business For Pharmaceutical Companies, Ease Financial Roadblocks

Source: International Business Times

European and U.S. pharmaceutical companies have always been allowed to sell medicines and medical devices in Iran, even if they've been hesitant about doing so. But the nuclear deal reached Tuesday could be transformative, not so much by peeling back legal restrictions on the pharmaceutical industry, but rather by tearing down financial roadblocks that could make it significantly easier for companies to do business in Iran in a sector that analysts say is teeming with growth opportunities.
Friday, July 17, 2015 — No Region Specified

Sanofi Unveils Restructuring Plans, Prunes Business Units

Source: Zacks Investment Research

Sanofi’s (SNY - Analyst Report) newly appointed Chief Executive Officer Olivier Brandicourt, after just three months of being at the helm, has made a big move by declaring plans to reorganize its business. Brandicourt intends to restructure the seven existing business units into five global business units. Along with its existing vaccines unit – Sanofi Pasteur – and the animal health business – Merial, the company plans to create three new global business units, namely, General Medicines & Emerging Markets, Specialty Care and Diabetes & Cardiovascular.
Wednesday, July 15, 2015 — Sub-Saharan Africa

Caveats, Costs and Complexities Shadow First Malaria Vaccine

Source: Reuters

It's a showpiece drug that has the potential to end a disease that kills half a million African children a year. Yet even before it wins a license, the world's first malaria vaccine has lost some of its sheen.
Wednesday, July 15, 2015 — South Asia

Pharma Price Control Has Stunted Innovation, Study Finds

Source: The Times of India

Consumers may be happy at a cut in medicine bills but the government's price control measures have forced many brands out of the "unviable" pharmaceutical market, resulting in a drastic slowdown in new launches in the last five years.
Wednesday, July 8, 2015 — South Asia

Can CSR Funds Make a Difference in Healthcare?

Source: Livemint

The statistics tell a grim story. India carries 20% of the world’s disease burden, according to data from the World Health Organization (WHO). About 75% of deaths globally are caused by communicable diseases, of which India accounts for 17%. A report published in May by British charity Oxfam says India records the highest number of maternal deaths in the world.
Tuesday, July 7, 2015 — South Asia

Why Pharmaceutical Firms in India Hardly Took the Village Road

Source: The Economic Times

It's easier to spot an auto showroom in a small town than to locate a pharmacy that sells anything beyond cough and cold, and birth-control pills.
Wednesday, June 24, 2015 — No Region Specified

Global Health Advocates Circle U.S. Capitol, but Senators Advance Toward TPP Trade Deal

Source: Science Speaks

Representing organizations that train and supply health workers in some of the world’s poorest countries, that push for global access to life-saving medicines, and that urge effective responses to infectious diseases, protesters opposing the Trans Pacific Partnership took their message to the streets outside of lawmakers’ offices this morning in an effort to change just a few minds.
Monday, June 22, 2015 — South Asia

WHO names Vietnam a new global vaccine supplier

Source: Thanh Nien News

Vietnam has become the 37th country and the fifth in the Western Pacific meeting requirements to produce vaccines for the global market, the World Health Organization said.
Thursday, June 18, 2015 — Sub-Saharan Africa

Want international growth? Africa's set to double pharma sales in 5 years

Source: Fierce Pharma

Pharma growth in China may be slowing and Europe stalling, but there's one area where drugmakers might actually achieve some big growth, according to McKinsey & Co. That's Africa, a mere $4.7 billion market in 2003 and $20.8 billion a decade later.
Wednesday, June 17, 2015 — No Region Specified

Merck Manuals Health Guides Go Digital, and Free, in Global Push

Source: Reuters

Merck Manuals, the widely used health guides provided by drugmaker Merck & Co, are moving to a digital-only format in 10 different languages as part of an effort to educate the global community on medical issues.
Monday, June 15, 2015 — No Region Specified

Gavi to heighten engagement with countries transitioning into Vaccine Alliance

Source: Vaccine News

The Vaccine Alliance recently announced a series of actions that will support the new goals of the Alliance’s 2016-20 strategy, and the Gavi Board has chosen to assist the countries making the transition into the new practices.
Friday, June 12, 2015 — South Asia

MSF urges India not to 'cave to pressure' on affordable drugs

Source: Reuters

Charity Medecins Sans Frontieres appealed to India on Thursday not to give in to pressure from Europe, the United States and Japan to make it easier for big firms to get patents in the country, potentially blocking the production of cheap generics.
Thursday, June 4, 2015 — Sub-Saharan Africa

Campaign for Affordable Medicine Gains Ground in South Africa

Source: Inter Press Service

Patient and leading health organisations in South Africa have now joined a Fix the Patent Laws campaign launched in 2011 by Treatment Action Campaign (TAC) and Doctors Without Borders (MSF) to push for reform of the country’s current patent laws.
Wednesday, June 3, 2015 — Sub-Saharan Africa

What Does It Really Mean to Build Health Systems?

Source: Devex

Over the past year, discussions around dealing with the Ebola outbreak to bringing cases down to zero invariably circled around the need for health systems strengthening.
Tuesday, June 2, 2015 — No Region Specified

Japanese Companies Attack Neglected Diseases

Source: New York Times

Several Japanese drug companies have joined a new project to find medicines to treat two neglected parasitic diseases, Chagas and leishmaniasis.
Monday, June 1, 2015 — Sub-Saharan Africa

'One in 10 Malaria Drugs in Nigeria Is of Poor Quality'

Source: AllAfrica

New research released recently has indicated that substandard medicines are more prevalent than fake ones in world's most malaria-burdened country, Nigeria.
Friday, May 29, 2015 — No Region Specified

Could Viagra make it harder to spread malaria?

Source: CNET

Researchers from the Pasteur Institute in Paris found that drugs like Viagra may be effective in preventing malaria from spreading from person to person by stiffening up the parasite that causes it.
Friday, May 29, 2015 — No Region Specified

Antibiotic Alternatives Rev Up Bacterial Arms Race

Source: Scientific American

More than eight decades have passed since Alexander Fleming’s discovery of a fungus that produced penicillin — a breakthrough that ultimately spawned today’s multibillion-dollar antibiotics industry. Researchers are now looking to nature with renewed vigor for other ways of fighting infection.
Wednesday, May 27, 2015 — Sub-Saharan Africa

GlaxoSmithKline Invests £5.85m to Train 9,000 Health Workers in Ghana, Kenya, Nigeria

Source: Ghana Business News

GlaxoSmithKline (GSK), a British multinational pharmaceutical company, has rolled out a three- year healthcare programme to support the training of more than 9,000 health workers in Ghana, Kenya and Nigeria.
Tuesday, May 26, 2015 — No Region Specified

PRESS RELEASE: Governments take decisive step towards more affordable vaccines

Source: Doctors Without Borders

Governments meeting in Geneva for the annual World Health Assembly raised the alarm Sunday on the exorbitant rise in the price to vaccinate a child, and took a decisive step towards addressing the problem by passing a resolution which called for more affordable vaccines and greater transparency of vaccine prices.
Tuesday, May 26, 2015 — Sub-Saharan Africa

Merck Opens Telehealth Clinics for Patients in Rural Africa Areas

Source: HIT Consultant

Merck, in partnership with Kenya Ministry of Health, kicked off their first telehealth clinics at both of Kenyatta National Hospital in Nairobi and Machacos Hospital as a part of their e-health initiative in Africa.
Friday, May 22, 2015 — Sub-Saharan Africa

Building the Business Case for Health Sector Strengthening

Source: Devex

As the Ebola virus in West Africa wanes, multilateral and bilateral donors along with NGOs and country governments are making a concerted push to strengthen health systems across the developing world to protect against future health crises.
Monday, May 11, 2015 — No Region Specified

Hunt for AIDS Cure Accelerates As GSK and U.S. Experts Link Up

Source: Reuters

Britain's GlaxoSmithKline , which decided last week to retain rather than float off its HIV drugs business, is to collaborate with U.S. scientists in developing a cure for AIDS.
Friday, May 1, 2015 — No Region Specified

Solid, heat-resistant vaccine to ease immunisation processes

Source: MedicalXpress

EU researchers have set out to substitute liquid and freeze-dried vaccines for new, solid state candidates. If successful, the research will enable the large scale production of new virosome-based vaccines with increased stability, longer shelf life and less invasive administration methods.
Thursday, April 30, 2015 — South Asia

India explores 'heat-proof' vaccines to stop vital medicines going to waste

Source: Daily Mail

As India is witnessing wastage of at least 50 per cent of vaccines stocked by various healthcare agencies owing to heat exposure, the Central Drugs Standard Control Organisation (CDSO) has decided to explore the idea of developing thermostable vaccines.
Thursday, April 30, 2015 — No Region Specified

Public health: Behind a vaccine

Source: Nature

In August 2014, officials from the World Health Organization (WHO) called global-health specialist Adrian Hill, who is the director of a non-profit vaccine-research centre. They had an urgent question: how soon could the centre launch a clinical trial for an Ebola vaccine? ... Within a month of the phone call, the institute had launched an Ebola-research initiative.
Friday, April 24, 2015 — No Region Specified

Campaign Launched to Cut Price of Penumonia Vaccine

Source: OneWorld

A global campaign is calling on GlaxoSmithKline (GSK) and Pfizer to slash the price of the pneumonia vaccine in developing countries to $5 or less per child.
Tuesday, April 14, 2015 — No Region Specified

Pharmaceutical Company Operates With the Heart of a Nonprofit, Soul of Social Enterprise

Source: MintPress News

A San Francisco-based pharmaceutical company is bringing a new contraceptive to the U.S. market. The product is Liletta, an intrauterine device (IUD), which, like any other IUD, is long-lasting and highly effective at preventing pregnancy when inserted properly.
Friday, April 3, 2015 — South Asia

Chinese Pharma: A Global Health Game Changer?

Source: Council on Foreign Relations

The twenty-first century shift in geoeconomic power toward Asia has also spurred a rebalancing in global pharmaceutical research and development (R&D) investment toward emerging economies. China is currently the world’s second-highest investor in R&D and is poised to overtake the United States in R&D spending by 2023. Determined to become a world leader in the pharmaceutical sector, China spent $1.17 billion on promoting life and medical sciences in 2012—nearly ten times its 2004 level of investment. With U.S. funding for medical research on the decline, the surge in Chinese funding has prompted many policymakers to ask if the country's pharmaceutical industry could be the next game changer for global public health and access to medicine (ATM).
Thursday, April 2, 2015 — Sub-Saharan Africa

GlaxoSmithKline and Merck Ebola Vaccines Succeed in Phase II Liberian Trials

Source: FiercePharma

Two Ebola vaccines, one developed by the NIH and GlaxoSmithKline ($GSK) and the other by Merck ($MRK) and NewLink ($NLNK), have sailed through Liberian trials and, based on the results, may now advance to Phase III trials.
Monday, March 30, 2015 — Sub-Saharan Africa

Doctor-Turned-Entrepreneur Bullish About Ethiopia’s Healthcare Sector

Source: How We Made It In Africa

As Africa’s second most populous country, Ethiopia’s healthcare industry holds significant potential. According to Dr Mohammed Nuri (42), founder and CEO of local pharmaceutical company Medtech Ethiopia, the industry commands more than 18bn Ethiopian birr (about US$881m) in annual sales. In recent years imports from abroad have risen, while foreign investors have entered partnerships with local players.
Friday, March 27, 2015 — No Region Specified

Why Aren’t We Producing Medications for Looming Global Disease Threats?

Source: The Washington Post

In the United States, any cluster of tuberculosis cases makes headlines, no matter how small the numbers. For example, local health authorities recently issued a warning to medical providers after 15 residents of a New York City neighborhood contracted tuberculosis over a two-year period — and the tabloids promptly hyped the news.
Tuesday, March 24, 2015 — No Region Specified

Pharmaceutical Incentives Cost Lives, Yale Professor Says

Source: Yale Daily News

A Yale paper published online on Feb. 11 in the Journal of Global Health argues that implementation of a new agency to fund pharmaceutical companies could have decreased the severity of the recent Ebola outbreak.
Monday, March 23, 2015 — No Region Specified

Viewpoint: Not Free Vaccines, Mr. Gates, Just Sustainably-Priced Ones

Source: The Lancet

Advocates working to increase global access to medicines were frustrated by the recent comments made by Bill Gates publicly criticizing Médecins Sans Frontières (Doctors without Borders, MSF) for calling for reductions in the prices of new vaccines. In doing so, Mr Gates stands by a system of pricing that requires raising billions of dollars in donor funding every year to support it. We believe that a system dependent on raising massive amounts of money to meet arbitrarily high prices set by the pharmaceutical industry is a failed system and should be acknowledged as such by donors like Mr Gates. Rather, true success in global vaccination requires mechanisms that can rapidly achieve long-term sustainable vaccine pricing.
Friday, March 20, 2015 — No Region Specified

Charity Attacks Gilead Over Hepatitis C Drug Restrictions

Source: Reuters

Charity Medecins Sans Frontieres has accused U.S. drugmaker Gilead Sciences Inc GILD.O of restricting access to its breakthrough hepatitis C drug Sovaldi in developing countries as it tries to protect profit margin in wealthier nations.
Thursday, March 19, 2015 — No Region Specified

New Initiatives Launched with €365M to Tackle Major Global Health Problems

Source: Science|Business

A £195M fund to address antimicrobial resistance and a $100M VC fund to spur drug discovery in dementia, both announced by the UK government this week, aim to build international coalitions to deal with these threats.
Wednesday, March 18, 2015 — Sub-Saharan Africa

M&A Activity Set To Increase In Africa’s Health Sector

Source: AFK Insider

Mumbai-based pharmaceutical major Lupin Ltd.'s buyout of the remaining 40 percent equity stake in South Africa’s generic drug maker Pharma Dynamics at undisclosed amount last week shed light on other potential windfalls for Africa’s health-care investors.
Tuesday, March 17, 2015 — South Asia

Indian Pharma Firms Must Innovate in Face of Generic Drugs Slowdown

Source: Zee News

Indian pharmaceuticals companies need to diversify their product range and focus on evolving as innovators as growth in generic market is expected to slow down over the next decade, a study by industry body Assocham said on Monday.
Monday, March 16, 2015 — No Region Specified

What Gates Foundation's $52M Investment Says About Social Enterprise Funding

Source: Forbes

Social enterprises seeking financing face a great many hurdles that more-traditional ventures don’t have to tackle.
Thursday, March 12, 2015 — Sub-Saharan Africa

Getting a New Contraception Option to Market: How Public-Private Partnerships Drive Innovation

Source: PSI Impact

The modern Senegalese woman has it together. From raising children to owning a small business, ambition and poise are valued by Senegalese women, according to market research conducted by PSI and its partners before the launch of a new contraceptive option called Sayana Press.
Thursday, March 12, 2015 — South Asia

India Introduces Its Own $1 Rotavirus Vaccine

Source: RYOT News

On March, 9, India introduced its first ever indigenously produced vaccine for the Rotavirus.
Wednesday, March 11, 2015 — South Asia

Vaccine Worth $1.3m ‘Goes Bad’ in Health Ministry Store

Source: DAWN

Pentavalent Vaccine worth $1.3 million, enough to vaccinate 400,000 infants against five potentially deadly diseases, has spoiled in a storage room at the National Health Services (NHS) Ministry. Three junior officials have been suspended for negligence which resulted in the temperature variation causing the vaccine to spoil.
Monday, March 9, 2015 — South Asia

Will Indian Generic Pharma Players Live Up to Their Billing?

Source: Deccan Herald

Compared with many other industries in the country, save for the software industry, the Indian pharmaceutical sector’s performance has been impressive and its future secure.
Thursday, March 5, 2015 — No Region Specified

Global Health Justice Partnership calls for action to lower drug prices

Source: Yale Daily News

Yale’s Global Health Justice Partnership has released a report warning the international community that scientific discoveries will not be enough to prevent the over 500,000 deaths that occur every year from Hepatitis C.
Monday, March 2, 2015 — South Asia

Pakistan wastes $3.7 million worth of donated vaccine, official says

Source: The Daily Mail

Pakistan has wasted $3.7 million worth of vaccines donated to protect children from deadly diseases because officials failed to store them properly, a senior health official told Reuters on Monday.
Monday, March 2, 2015 — South Asia

Drug-resistant malaria threatens to spread to India causing global health crisis

Source: The Independent

Mutant genes that are resistant to a vital anti-malaria drug were found in the blood of people close to the India border.
Thursday, February 26, 2015 — Sub-Saharan Africa

Big Pharma, NGO Square the Circle on Access to Vaccines

Source: EurActiv

One would expect a multinational pharmaceutical group and a leading humanitarian NGO to hold radically opposed views on access to vaccines.
Thursday, February 26, 2015 — No Region Specified

World Trade Organization Least-Developed Countries Request Waiver of Intellectual Property Rights on Pharma Products

Source: Intellectual Property Watch

This week at the World Trade Organization intellectual property committee meeting, least-developed countries submitted a request to extend a waiver allowing them not to enforce intellectual property rights on pharmaceutical products. The countries have extended the waiver before, but this time they are seeking to make it indefinite, until they are no longer considered LDCs.
Wednesday, February 25, 2015 — No Region Specified

Merck Places Children's HIV Drug in Shared Non-Profit Patent Pool

Source: Reuters

U.S. drugmaker Merck & Co has contributed an HIV medicine for children to an international shared patent pool in a move that should speed the development of cheap paediatric formulations for use in poor countries.
Tuesday, February 24, 2015 — Asia Pacific

As Overseas Money Dries Up, Indonesia Develops Its Own Vaccines

Source: EurActiv

Indonesia is developing its own vaccines to fight infectious diseases because funds from the EU and other development agencies to its health sector are drying up. EurActiv reports from Indonesia.
Tuesday, February 24, 2015 — No Region Specified

New Deal Allows Generics Makers License to Sell HIV Drug

Source: Devex

Children living with HIV in 92 countries may soon have access to a lower-cost antiretroviral treatment.
Thursday, February 19, 2015 — No Region Specified

New Tuberculosis Drug Enters First Trial: The Good and Sad News

Source: Devex

The maiden human trial of a potential tuberculosis drug — the first in six years — has now commenced.
Wednesday, February 18, 2015 — South Asia

Global Pharma's R&D Re-Balancing

Source: Forbes

Earlier this week, in Michael Woodhead’s superb blog China Medical News, he wrote about “major problems with ‘serious’ research clinical trails carried out in China.” Michael points to a JAMA article and then proceeds to elaborate:
Monday, February 16, 2015 — No Region Specified

Press Release: Afaxys Pharmaceuticals Partners with Project Ruby to Bring Affordable Contraceptives to Women Worldwide

Source: Business Wire

Afaxys Pharmaceuticals, a division of Afaxys, Inc., is proud to announce a first-of-its-kind partnership with Project Ruby (PRJKT RUBY), an innovative online platform, to bring affordable contraceptives to women in the United States and the developing world.
Friday, February 13, 2015 — No Region Specified

Hospira Buyout Is a Shot in the Arm for Pfizer’s Biosimilars

Source: Chemistry World

US pharma giant Pfizer aims to bolster its sterile injectable capabilities and gain access to biosimilars by buying injectables specialist Hospira. Pfizer anticipates that the $17 billion (£11 billion) deal will result in $800 million in savings by 2018.
Wednesday, February 11, 2015 — No Region Specified

Vaccines Are Profitable, So What?

Source: The Atlantic

By now, the numbers on the recent U.S. measles outbreak are well known. In 2014, America had more than 600 cases of measles—the highest number in 20 years. In the month of January 2015 alone, 84 people in 14 states reported having measles, with most cases linked to an incident at Disneyland. The reason for the resurgence? More and more people are opting to not vaccinate their kids.
Wednesday, February 11, 2015 — Europe & Eurasia

Profit for Good at Rottendorf Pharmaceuticals

Source: Outsourced Pharma

Let’s deal with the name first. If you’re like me, it would’ve been a distraction throughout the article if we hadn’t. The company is named after its German founder and patron, Andreas J. Rottendorf (1897-1971). As per the organization’s founding charter, it can’t be changed.
Wednesday, February 11, 2015 — No Region Specified

A Working Malaria Vaccine that Can't Get Money

Source: Newsweek

Tucked away in a few rooms within the Alexandria Life Science and Translational Research Center in Rockville, Maryland, is a 48-member biotechnology company pursuing a singular obsession to eradicate one of the greatest global health challenges in history, malaria. “We’re swinging for the knockout,” says Dr. Stephen Hoffman, who founded Sanaria in 2003. “This is not to take anything away from the incredibly successful work others are doing to distribute bed nets, create educational programs to increase malaria literacy or discover better methods to deliver existing antimalarials. Those efforts are vitally important. But we’re searching for the one blow that will finally end humanity’s fight against this ancient disease: a vaccine.”
Friday, February 6, 2015 — Asia Pacific

Japanese Foundation Joins the Public Health Grand Challenge Bandwagon

Source: AAAS

A Japanese foundation will try to discover innovative approaches to neglected infectious diseases with a Grand Challenge.
Wednesday, February 4, 2015 — Sub-Saharan Africa

Pharmaceutical Industry in West Africa Receives a Boost

Source: Spy Ghana News

To ensure affordability, safe, quality and efficacious medicines on the African continent, the West Africa Medicines Registration Harmonization Project and Steering Committee of African Union Model Law, has been launched in Accra.
Wednesday, February 4, 2015 — No Region Specified

Press Release: Study Shows the Top Ten Global Health Pharmaceutical Supply Chain Issues

Source: Newswise

Ten years after the 2005 Paris Declaration on Aid Effectiveness reported on the need for better coordination in the global fight against disease, global pharmaceutical supply chains remain fragmented and lack coordination, facing at least 10 fundamental challenges, according to a newly published paper by professors at NYU Wagner and MIT-Zaragoza.
Friday, January 30, 2015 — Sub-Saharan Africa

Study: Ebola Vaccine May Fall Short

Source: Voice of America

One of the Ebola vaccines about to enter testing in Liberia may not be as potent as researchers had hoped, according to a new study, raising questions about how well it will prevent infection.
Thursday, January 29, 2015 — South Asia

International Health Activists Criticise President Obama’s Attempts to Undermine India's IPR

Source: Pharmabiz

US President Barack Obama’s comments during the India-US CEO Forum in New Delhi on Monday January 26 with Indian Prime Minister Narendra Modi have drawn harsh criticism from international health activists. The activists have called upon Indian Prime Minister Narendra Modi to stand strong against US pressure to change its pro-public health patent laws.
Wednesday, January 28, 2015 — No Region Specified

Bill Gates Dismisses Criticism of High Prices for Vaccines

Source: The Guardian

Criticising the cost of vaccines could lead to pharmaceutical companies withdrawing research funding, warns Gates, as donors pledge $7.5bn for immunisations of children in poor countries.
Tuesday, January 27, 2015 — South Asia

Top-Selling Vaccine Made Cheap Shows Challenge to Merck

Source: Bloomberg

Asia’s biggest vaccine maker is working on a string of new low-priced offerings that threaten to undercut brands from the world’s biggest pharmaceutical companies.
Friday, January 23, 2015 — No Region Specified

Developing Countries Urged to Produce TB Vaccines Locally

Source: EurActiv

Even though one third of the global population have the microbes that cause tuberculosis (TB), pharmaceutical companies still have little incentive to produce the drugs that can combat the deadly but curable disease.
Thursday, January 22, 2015 — No Region Specified

MSF Bends Donation Policy for Pneumonia Vaccine

Source: Devex

After years of refusing vaccine handouts from big pharmaceutical companies, international medical humanitarian group Médecins Sans Frontières is bending its policy to accept donations of the pneumococcal conjugate vaccine.
Wednesday, January 7, 2015 — Asia Pacific

Japanese Drugmakers Addressing Neglected Tropical Diseases, and Not Just Out of Altruism

Source: The Japan Times

Japanese drugmakers are developing medicines to treat infectious diseases that have been overlooked because there is little financial incentive.
Monday, January 5, 2015 — South Asia

OPINION: Let India Make Cheap Medicines

Source: Deccan Herald

Last November, the United States and India announced an important breakthrough concerning India’s “right-to-food” programme.
Tuesday, December 23, 2014 — Sub-Saharan Africa

Ebola Vaccine Trial in Africa May Support More Potent Version

Source: Bloomberg

An experimental Ebola vaccine showed it was safe and generated an immune response in healthy Ugandan adults in a clinical trial that bodes well for a more potent version undergoing testing.
Friday, December 19, 2014 — No Region Specified

Incentive Program May Alter the Economics of Ebola Vaccines

Source: CP24

Earlier this week, U.S. President Barack Obama signed into law a little piece of legislation that may significantly change the economics of making drugs or vaccines to protect against Ebola and other viruses in its deadly family.
Tuesday, December 9, 2014 — No Region Specified

Merck's $9.5 Billion Cubist Deal is Really About the Global War on Drug-Resistant Bacteria

Source: International Business Times

Merck & Co. is paying $8.4 billion in cash and assume $1.1 billion in net debt to acquire Cubist Pharmaceuticals Inc. and join the fight against drug-resistant bacteria — a growing global threat that's slowly fueling a lucrative pharma business.
Friday, December 5, 2014 — South Asia

India 'Too Reliant' on Chinese Drug Imports, Worries Delhi

Source: BBC

There's loud chatter in Mandarin, Hindi and English - all thrown in a heady mix of business, big numbers, and of course money converted in at least two currencies.
Wednesday, December 3, 2014 — No Region Specified

Delivering Twice As Many Pharmaceuticals At Half The Cost Is Now A Reality

Source: Digital Journal

Eulysis UK Limited's mission is to revolutionise pharmaceutical delivery globally. The Single Vial System (SVS), their unique storage and reconstitution technology for lyophilized (freeze-dried) pharmaceuticals is just 9 months away from becoming commercially viable.
Tuesday, December 2, 2014 — Sub-Saharan Africa

OPINION: Africa: The Economics of Pro-Poor Health Policy

Source: allAfrica

The Southern African Development Community (SADC) can learn from the difficulties faced by the Economic Community of West African States (ECOWAS) in curtailing the spread of Ebola.
Monday, December 1, 2014 — Sub-Saharan Africa

Needling Questions On China In Africa

Source: Caixin Online

In a recent agreement, the China-Africa Development Fund and Wuhan-based Humanwell Healthcare (Group) Co. inked a deal to open a pharmaceutical factory in Bamako, Mali, as part of a series of healthcare sector investments in Africa.
Monday, December 1, 2014 — South Asia

MNCs Deprive India Of Vital Drugs Despite Getting Monopoly Rights

Source: The Economic Times

Some multinational companies (MNCs) have been delaying the launch of life-saving drugs in India years after getting monopoly rights, while cheaper generic versions of exorbitantly-priced medicines are going off the shelves under the product patenting law.
Monday, November 24, 2014 — Sub-Saharan Africa

Investment in Nigeria’s Pharmaceutical Sector Hits N70 Billion

Source: Business Day

Investment in Nigeria’s pharmaceutical sector has hit N70 billion in the last four years, the Pharmaceutical Manufacturers Group of the Manufacturers Association of Nigeria (PMG-MAN) revealed to BusinessDay.
Thursday, November 20, 2014 — No Region Specified

Gilead Buys Shortcut For FDA Drug Review For $125 Million

Source: NPR

How much is a fast track for the Food and Drug Administration review of a new drug worth? Try $125 million.
Thursday, November 20, 2014 — No Region Specified

OPINION: Déjà Rule: The Health Damaging Consequences of Reinstating the Global Gag Rule in 2015

Source: The Huffington Post

This year, the Foreign Operations Bill proposed by the House of Representatives includes the restoration of $300 million in funding for the successful President's Emergency Plan for AIDS Relief (PEPFAR), which has been chronically underfunded in recent years.
Monday, November 17, 2014 — No Region Specified

Breaking the R&D deadlock: could Open Labs be the key to cracking the world’s toughest health problems?

Source: The Lancet

In January, 2010, an unprecedented step was taken to progress research into diseases of the developing world when global pharmaceutical company GSK announced it was creating the world’s first Open Lab. ... Four years since its creation, the Open Lab model is emerging as a success story.
Friday, November 14, 2014 — No Region Specified

Pfizer and Aid Groups Team Up on Depo-Provera Contraceptive for Developing World

Source: The New York Times

Depo-Provera, an injectable contraceptive given once every three months, is already a popular choice of women in developing countries, who value the convenience and discretion of not having to take a daily birth control pill. But the injections are out of reach for many more women.
Wednesday, November 12, 2014 — South Asia

India takes action on spurious and sub-standard drugs

Source: The Pharma Letter

An American pharmacist and an Indian pharmacologist charged with smuggling four million fake pharmaceuticals into the country earlier this month may have been the last straw for the Indian government battling counterfeit drugs.
Monday, November 10, 2014 — South Asia

Sanofi launches paediatric vaccine Shan5 in India

Source: Business Standard

With the launch of Shan 5 in India, 27 million babies born annually will have access to vaccination.
Friday, November 7, 2014 — No Region Specified

Pharmaceuticals industry facing fundamental change

Source: BBC News

Pharmaceuticals is an extraordinarily profitable business.
Friday, November 7, 2014 — Sub-Saharan Africa

Can We Rely on the Private Sector to Halt Malaria in Africa?

Source: Newsweek

Aid organizations are selling discount drugs directly to shopkeepers in hopes of quelling the parasitic disease
Thursday, November 6, 2014 — No Region Specified

World's 1st dengue vaccine likely by 2015: Sanofi

Source: The Economic Times

As India deals with increasing number of dengue fever, pharma major Sanofi today said the world's first vaccine against the mosquito-borne viral disease may be available by the second half of 2015.
Wednesday, November 5, 2014 — Sub-Saharan Africa

Bill Gates-Backed Group Weighs Funding for Ebola Vaccine

Source: Bloomberg

As GlaxoSmithKline Plc (GSK) and other drugmakers race to develop and deploy vaccines against West Africa’s Ebola outbreak, one key question remains: who will pay?
Monday, November 3, 2014 — No Region Specified

Good for health, good for business

Source: Devex

Why would a global corporation reinvest 20 percent of its profits from developing countries back into training health workers? It’s simple. Health workers are the driver of health systems.
Friday, October 31, 2014 — South Asia

Eli Lilly shares MDR-TB drug technology with Shasun Pharma

Source: LiveMint

US drug maker Eli Lilly and Company said on Thursday that it had shared the manufacturing technology for two antibiotic drugs meant for the treatment of multi-drug resistant tuberculosis (MDR-TB) with India’s Shasun Pharmaceuticals Ltd as part of its ongoing programme to increase access of these medicines in countries including India, China, Russia and South Africa, where drug-resistant TB is most prevalent.
Monday, October 27, 2014 — Sub-Saharan Africa

WHO certification puts Nigerian pharmaceutical industry in global watch

Source: Business Day

The Good Manufacturing Practice (GMP) certification given to three local drug firms by the World Health Organisation (WHO) has put the Nigerian pharmaceutical industry in the global eye.
Thursday, October 23, 2014 — No Region Specified

Drugmakers may need indemnity for fast-tracked Ebola vaccines

Source: Reuters

Drugmakers are looking for some kind of indemnity from governments or multilateral agencies against possible losses or claims arising from the widespread emergency use of new Ebola vaccines in Africa.
Wednesday, October 22, 2014 — No Region Specified

Drugmakers to join forces to make millions of Ebola vaccine doses

Source: Reuters

Leading drugmakers plan to work together to accelerate development of an Ebola vaccine and produce millions of doses of the most effective experimental product for use next year.
Wednesday, October 22, 2014 — South Asia

Pharma companies feel law change can weaken ability to provide low-cost drugs

Source: The Economic Times

Indian drugmakers and public health activists are deeply worried that sections of the American pharmaceutical industry may use the recently announced Indo-US working committee on intellectual property rights to force changes in Indian patent laws to further their commercial interests at the cost of the domestic industry.
Friday, October 17, 2014 — No Region Specified

PRESS RELEASE: Investing in local production of medicines is a priority

Source: UNAIDS

A high-level meeting held in Geneva, Switzerland, explored how countries can improve access to medicines and develop their domestic production, with the help of public and private investment.
Friday, October 17, 2014 — Sub-Saharan Africa

Issues continue to dog the testing of Ebola drugs and vaccines

Source: Science MagazIne

The fact that no “flexible and innovative protocol” exists for Ebola speaks to the complex practical and ethical issues that surround the use of untested drugs and vaccines in the midst of the explosive spread of a virus that kills more than half the people it infects.
Thursday, October 16, 2014 — South Asia

India to enter top two markets for health company Abbott

Source: Times of India

Close on the heels of Prime Minister Narendra Modi's "Make in India" call, global health giant Abbott is setting up a Rs 450-crore plant for manufacturing nutrition products in Jhagadia, Gujarat.
Wednesday, October 15, 2014 — Sub-Saharan Africa

Profit motive big hurdle for Ebola drugs, experts say

Source: MedicalXpress

For nearly four decades, mention of the Ebola virus has evoked death and terror, yet a simple factor—money—has stood in the way of erasing the curse, experts say.
Tuesday, October 14, 2014 — South Asia

Pharmaceutical companies, WHO help India in HIV/AIDS drug crisis

Source: Reuters

(Reuters) - Indian companies and global health groups are stepping up efforts to provide a critical medicine for the country's free HIV/AIDS drugs program after more than 150,000 patients risked going without their dosages this month.
Friday, October 10, 2014 — No Region Specified

Pfenex And PATH Partner On Vaccines

Source: Benzinga

Pfenex Inc., a clinical-stage biotechnology company engaged in the development of high-value biosimilar therapeutics and difficult to manufacture proteins, today announced the initiation of a multi-product research program with PATH.
Wednesday, October 8, 2014 — No Region Specified

Vaccines targeting adults, teens best chance to eliminate TB

Source: Business Standard

Targets to eliminate tuberculosis (TB) by 2050 are more likely to be met if new vaccines are developed for adults and adolescents rather than infants, according to a new research.
Wednesday, October 8, 2014 — Sub-Saharan Africa

Ebola Vaccine Trials May Give Placebo to Those at Risk

Source: Bloomberg Businessweek

As global health officials rush to begin human trials of two promising Ebola vaccines in West African medical workers, a daunting question remains unanswered: Who gets the placebo injection?
Tuesday, October 7, 2014 — South Asia

The Dangers of the Indian Government’s Flirtation with U.S. Pharma and Risks for India’s Coherent, Pro-Public Health IP Policy

Source: Equilibri

India’s new Prime Minister, Narendra Modi and his delegation, who have been visiting the U.S. for the first time, have spent considerable time and energy in courting U.S. business interests.
Monday, October 6, 2014 — South Asia

Over the counter drug market to reach $6.6 billion by 2016

Source: The Economic Times

The over the counter (OTC) drug market in India is expected to grow to $6.6 billion by 2016 with pharma companies and chemists increasing their presence in the rural market.
Friday, October 3, 2014 — South Asia

US consumer giant seeks to smash India menstruation taboos

Source: YourHealth

The latest commercial for Procter & Gamble's top-selling brand of sanitary pads in India ticks all the usual boxes - a young woman jogs happily in pristine white trousers, before effortlessly winning a tennis tournament.
Thursday, October 2, 2014 — No Region Specified

Plant-based vaccines challenge big pharma

Source: Health24

The recent revelation that the Ebola drug ZMapp is produced in the leaves of tobacco plants captured global attention.
Thursday, October 2, 2014 — No Region Specified

GlaxoSmithKline, NewLink working to bring Ebola vaccines online: WHO

Source: Yahoo! News

Both GlaxoSmithKline and NewLink Genetics are working to boost their capacity to make Ebola vaccines, with a goal of a "very significant increase in scale during the first half of 2015," the World Health Organization said on Wednesday.
Wednesday, October 1, 2014 — Sub-Saharan Africa

Shares of Companies Testing Ebola Vaccines Rise

Source: ABC News

Shares of some companies that are studying potential vaccines for Ebola climbed after federal officials announced that the first case of the disease has been diagnosed in the U.S.
Wednesday, October 1, 2014 — Sub-Saharan Africa

Ebola Researchers Have A Radical Idea: Rush A Vaccine Into The Field

Source: NPR

Traditional means of containing Ebola aren't working fast enough to get ahead of the epidemic. So the question is: Will giving an experimental vaccine to willing volunteers help contain the disease or put people at greater risk?
Wednesday, October 1, 2014 — Sub-Saharan Africa

Mobile technology offers option to combat fake drugs in West Africa

Source: PCWorld

Cholera, malaria and the rapidly expanding threat of Ebola have hit African countries with a related health-care problem: the scourge of fake drugs.
Monday, September 29, 2014 — Sub-Saharan Africa

Scientists grapple with ethics in rush to release Ebola vaccines

Source: Reuters

Normally it takes years to prove a new vaccine is both safe and effective before it can be used in the field. But with hundreds of people dying a day in the worst ever outbreak of Ebola, there is no time to wait.
Monday, September 29, 2014 — Sub-Saharan Africa

Can We Rely on the Private Sector to Halt Malaria in Africa?

Source: Newsweek

NGOs are selling discount drugs directly to shopkeepers in hopes of quelling the parasitic disease.
Thursday, September 25, 2014 — No Region Specified

Ebola vaccines could be available by end of year

Source: UPI

Promising vaccines, developed by U.S. and Canadian companies and agencies, could be ready for use by December.
Wednesday, September 24, 2014 — Sub-Saharan Africa

Ebola drug trials to be fast-tracked in West Africa

Source: Reuters

Experimental Ebola drugs including compounds from Mapp Biopharmaceutical, Sarepta and Tekmira will be tested in affected West African states for the first time in a bid to fast-track trials, the Wellcome Trust said on Tuesday.
Friday, September 19, 2014 — No Region Specified

Wireless sensor warns if vaccines get too hot

Source: SciDev.Net

A wireless sensor that sends text message alerts to healthcare workers could help better protect temperature-sensitive vaccines and provide crucial data on storage, transport and distribution infrastructures in developing nations, according to its inventors.
Thursday, September 18, 2014 — Sub-Saharan Africa

The black market for Ebola survivors’ blood

Source: The Washington Post

Blood from Ebola survivors is rich with antibodies against the deadly virus, and since there is currently no approved drug to fight it, some have become desperate enough to take fate into their own hands and turn to the black market for an experimental serum made with survivors' blood.
Thursday, September 18, 2014 — South Asia

India Must Fix Its Drug Quality Problem

Source: Forbes

India’s newly elected Prime Minister Narendra Modi just launched his first official tour of the United States.
Monday, September 15, 2014 — Sub-Saharan Africa

Johnson & Johnson Announces New Grant to Harvard Medical School to Combat Drug-Resistant Tuberculosis

Source: Press release

Johnson & Johnson today announced its affiliate Janssen Pharmaceutica NV (Janssen) has entered into a novel collaboration with Harvard Medical School to address critical gaps in the global struggle against tuberculosis (TB).
Friday, September 12, 2014 — Sub-Saharan Africa

Glaxo’s Ebola Vaccine and the Rise of Tropical-Disease R&D

Source: The Wall Street Journal

Financial arguments may finally be leading Big Pharma to increase its minuscule investment in research and development of new drugs for tropical diseases.
Thursday, September 11, 2014 — Sub-Saharan Africa

Merck adds to African m-health

Source: ITWeb Africa

Merck, a German-based pharmaceutical company, has added to a growing amount of mobile-health (m-health) programmes across Africa, channelling efforts to boost SMS-based support systems to help diabetic patients manage their condition.
Friday, September 5, 2014 — Sub-Saharan Africa

Canada Ebola vaccine shipment to Africa stymied by logistics

Source: Reuters

Canada's experimental Ebola vaccine was stuck in the government lab that developed it as officials puzzled over how to safely transport it, three weeks after it was offered to Africa to fight the deadly epidemic.
Friday, September 5, 2014 — Sub-Saharan Africa

FDA rushes J&J, NewLink Genetics Ebola vaccines to clinical trials

Source: Fierce Vaccines

Another Big Pharma player is joining the hustle toward an Ebola vaccine as the death toll surpasses 1,900 victims, eclipsing the total number of people who died from the disease in all previous outbreaks combined.
Wednesday, September 3, 2014 — No Region Specified

Final trial confirms efficacy of Sanofi's dengue vaccine

Source: Reuters

French drugmaker Sanofi, developing the first vaccine against dengue fever, said its product reduced disease cases by 60.8 percent in a large final clinical trial. Sanofi has invested more than 1.3 billion euros ($1.7 billion) in the project, undertaking two decades of research on the world's fastest-growing tropical disease.
Thursday, August 28, 2014 — South Asia

USIBC Concludes Successful Pharmaceutical Mission to India

Source: Market Watch

The U.S.-India Business Council (USIBC) has concluded its Pharmaceutical Executive Mission to Delhi, India. The delegation expressed its commitment to the Indian market, called for further dialogue with the government on issues related to pricing and intellectual property, and discussed strategies for expanding greater access to healthcare and health insurance in India.
Wednesday, August 27, 2014 — No Region Specified

Global Health Investment Fund Leads Investment into Low-Cost Oral Cholera Vaccine for the World’s Poor

Source: GHIF News

South Korean biopharmaceutical company commits to manufacture a new and improved presentation of the vaccine at a target price of $1.00 per dose for public sector buyers.
Wednesday, August 13, 2014 — South Asia

Random decisions in pharma pricing bad for India’s health

Source: Economic Times India

On July 10, the National Pharmaceutical Pricing Authority (NPPA) arbitrarily fixed prices for all anti-diabetic and cardiovascular drugs outside the scope of the Drug Price Control Order (DPCO) 2013, with no warning to manufacturers.
Tuesday, August 12, 2014 — Sub-Saharan Africa

WHO backs use of experimental Ebola drugs in West Africa outbreak

Source: Reuters

It is ethical to offer unproven drugs or vaccines to people infected or at risk in West Africa's deadly Ebola outbreak, a World Health Organisation panel of medical ethics experts ruled on Tuesday, but cautioned supplies will be limited.
Friday, August 8, 2014 — South Asia

India has big plans for healthcare and pharma

Source: PM Live

The rumblings of an Indian healthcare earthquake have been gathering pace for some years but the arrival of a new government with a mandate of progressive reform promises to make the earth move for pharma.
Monday, August 4, 2014 — Sub-Saharan Africa

Ebola virus: Britain's top doctor accuses drug firms of dragging their heels in finding vaccine

Source: Mirror

Professor John Ashton said the pharmaceutical industry was being slow because it had only affected Africa and not the Western world
Monday, August 4, 2014 — No Region Specified

OPINION: On AIDS: Three Lessons From Africa

Source: The New York Times

An AIDS fable: Once upon a time, in the years after AIDS went from being a death sentence to a manageable disease, at least for people rich enough to take antiretroviral therapy, many of the people who ran the world believed that these medicines weren’t appropriate for residents of very poor countries.
Friday, August 1, 2014 — No Region Specified

U.S. under pressure to give potentially life-saving medication the green light as experts warn of global pandemic

Source: The Daily Mail

Health campaigners are today calling for U.S. authorities to speed up their approval of a new drug hoped to be the first cure for the deadly Ebola virus.
Wednesday, July 30, 2014 — No Region Specified

Computing a Cure for HIV

Source: Federal Telemedicine

HIV/AIDS has caused an estimated 36 million deaths, according to the World Health Organization and remains a major health issue worldwide.
Monday, July 28, 2014 — No Region Specified

Pricey Hepatitis C Drug Draws Criticism

Source: Voice of America News

To hear scientists talk about it, it’s nothing short of a wonder drug.
Thursday, July 24, 2014 — South Asia

Lax antibiotic controls raise fears of killer disease

Source: Economic Times India

NEW DELHI: A pharmacist swiftly pulls white boxes of powerful antibiotics from neatly stacked shelves behind him, and hands them over the counter without asking for a doctor's prescription.
Tuesday, July 22, 2014 — South Asia

Price caps on drugs hurt Indian units of global pharma firms

Source: Livemint

Widening of price controls adds pressure on the local units of global manufacturers to boost sales volumes
Tuesday, July 22, 2014 — South Asia

Drug price cut of vital medicines a global phenomenon

Source: Economic Times India

MUMBAI: It is not the Indian regulator who is the only one after drug companies to cut prices. Across the world, pharmaceutical companies are coming under pressure to reduce prices as concerns over growing healthcare costs force governments to target drug makers.
Thursday, July 17, 2014 — No Region Specified

High School Student 3D Prints Innovative Syringe Which Could Expand Vaccination Possibilities

Source: 3D Print .com

While some high school students were worrying about their school portraits or who might take them to the prom, Park City High School senior Peter Bermant was worrying about the problems with distributing vaccines in developing countries.
Wednesday, July 16, 2014 — Sub-Saharan Africa

Could HIV self-testing be a game changer in Africa?

Source: Thomson Reuters Foundation

In Africa, where fewer than half the people know their HIV status, HIV self-testing is being explored as a way of encouraging more individuals, particularly in high risk groups, to know their status as a first step to seeking treatment, an AIDS charity said on Monday.
Thursday, July 10, 2014 — Sub-Saharan Africa

‘eHealth For Africa’ initiative makes debut in Nigeria

Source: The Guardian Nigeria

AS part of efforts to strengthen health system in Nigeria, Novartis has introduced ‘eHealth For Africa’ initiative into the country – being an updated version of the Short Message Service (SMS) for Life system in public health facilities.
Thursday, July 10, 2014 — No Region Specified

Global Insulin Market Worth $47.54 Billion by 2020 Research Report Available Online

Source: WhaTech

Key industry participants include Sanofi, Novo Nordisk, Eli Lilly, Novartis, Biocon, Oramed Pharmaceuticals, Bristol-Myers Squibb, Takeda Pharmaceuticals, Dongbao Enterprise Group Co., Ltd. and others.
Tuesday, July 8, 2014 — Sub-Saharan Africa

Gates Foundation battling big new threat in malaria fight

Source: The Seattle Times

Just as Myanmar opens up to the world and becomes a place of economic opportunity, fears are rising over the spread of a drug-resistant form of malaria. But efforts are under way, including a big initiative of the Gates Foundation, to fight this problem.
Tuesday, June 24, 2014 — Sub-Saharan Africa

Serenus Biotherapeutics sees large potential market in Africa

Source: SFGate

San Francisco's newest pharmaceutical company is staking its future on a distant continent: Africa.
Tuesday, June 24, 2014 — South Asia

India likely to extend price caps to more drugs-sources

Source: Reuters

(Reuters) - India is likely to raise the number of drugs deemed essential and therefore subject to price caps to improve affordability, said people directly involved in the process.
Friday, June 6, 2014 — No Region Specified

Mounting concern as crippling virus reaches Caribbean,USA

Source: Thomson Reuters Foundation

Laurence, a 58-year-old Haitian woman who works in my building, woke up with sharp pain and fever and thought she was dying. She was unable to rise from her bed or hold a glass of water because of the pain in her joints. She could not believe this was a real disease, surmising it must be a voodoo spell that her neighbor put on her.
Tuesday, June 3, 2014 — No Region Specified

'Millions denied end-of-life drugs'

Source: BBC News

Lack of access to pain relief for dying patients is a "public health emergency", say experts.
Thursday, May 29, 2014 — No Region Specified

OPINION: We're All Liars: Creative Storytelling Is the Nonprofit Sector's Drug of Choice

Source: Huffington Post

On May 21, 2014, Newsweek funneled years of speculation and doubt into a single piece that, once and for all, brought the legendary Somaly Mam into the spotlight for a type of fraud that has become the Achilles heal of the nonprofit world.
Wednesday, May 28, 2014 — No Region Specified

GSK Announces Vaccine Price Freeze in Support of GAVI Alliance

Source: PharmTech

GSK reported that it would freeze the prices of its vaccines for five years for developing countries that graduate from GAVI Alliance. By committing to offer GAVI Alliance prices for vaccines against pneumococcal disease, rotavirus and cervical cancer, GSK will support developing country governments as they transition to financing the full cost of their local vaccination programs.
Tuesday, May 27, 2014 — No Region Specified

Zambia And IBM To Provide Increased Access To Life Saving Drugs

Source: ventures

VENTURES AFRICA – IBM has announced a collaboration with Zambia’s Ministry of Health to provide citizens with better access to 200 lifesaving drugs.
Friday, April 18, 2014 — No Region Specified

Ebola deaths rise to 135 as vaccine research lags

Source: FierceVaccines

As the death toll from the Ebola virus in West Africa climbs to 135 people, a vaccine to combat the deadly virus remains years out of reach.
Thursday, April 17, 2014 — No Region Specified

A New Public-Private Strategy to Combat Malaria and Tuberculosis

Source: Devex

Tuberculosis and malaria are two of the world’s most pervasive yet neglected diseases. Together, both affect one-third of the world’s population: three out of seven people globally are infected or at risk for malaria or TB, and one in seven are actually infected.
Thursday, April 3, 2014 — Sub-Saharan Africa

Donors Commit $240 Million to Fight Neglected Diseases

Source: Voa News

Bill Gates, the World Bank and other donors are stepping up efforts to fight neglected tropical diseases in Africa and other low-income regions with a $240 million injection of new funding.
Thursday, April 3, 2014 — South Asia

Dabbawallas to Spread Dengue, Malaria Messages in Mumbai

Source: The Times of India

On Monday, the city's 50,000-odd dabbawallas will tag a health message-'prevent and control vector-borne diseases'-to each of the two lakh tiffin boxes that they carry throughout the day.
Wednesday, April 2, 2014 — No Region Specified

UK Drug Firm to Set Up Plant in Rwanda

Source: All Africa

A Renowned British multinational pharmaceutical, GlaxoSmithKline, has listed Rwanda as one of the places it considers putting up a production plant as part of its move to form innovative partnerships to transform medicines supply in Africa.
Tuesday, April 1, 2014 — Sub-Saharan Africa

Balancing Profits Against Public Health in the Search for Innovative Vaccines

Source: Deutsche Welle English

There is no cure and no vaccine for the Ebola virus, which has killed about 70 people in Guinea. Vaccine expert Professor Adrian Hill tells DW why some vaccines take time. It's got to do with profit.
Tuesday, March 25, 2014 — Sub-Saharan Africa

Ebola Outbreak in Guinea May Spread to Liberia

Source: The Washington Post

An outbreak of the deadly Ebola virus is believed to have killed at least 59 people in Guinea and may already have spread to neighboring Liberia, health officials said Monday.
Monday, March 24, 2014 — No Region Specified

South Africa ground zero for reforming drug patents

Source: CMAJ

The government of South Africa is squaring off against drug makers over patent reform in the lead-up to national elections on May 7, citing a "massive disease burden" from HIV-AIDS, tuberculosis, hepatitis, cancer and heart diseases.
Tuesday, March 18, 2014 — South Asia

Huge Opportunities Await Indian Health Investors in Africa

Source: SME Times

In 2012, Africa accounted for almost a quarter of India's drug exports.
Friday, March 14, 2014 — No Region Specified

The quest for WHO prequalification by pharmaceutical firms

Source: Business Day

Annually, millions of patients in resource-limited countries receive life-saving medicines that are purchased by or through international procurement agencies such as World Health Organisation (WHO), United Nations Children Fund (UNICEF), United Nations Population Fund (UNFPA), UNITAID and the Global Fund to Fight AIDS, TB and Malaria.
Wednesday, March 12, 2014 — No Region Specified

Big Pharma still betting on "messed up" Indian drugs market

Source: Reuters

Global drugmakers have had a nauseous time in India's $14 billion market. Prices have dropped and valuable patents have been overruled as the authorities strive to make medicines affordable for the 70 percent of people living on less than $2 a day.
Tuesday, March 11, 2014 — Europe & Eurasia

German Company Wins Inaugural EU Prize For Innovative Vaccine Technology

Source: RTT News

The European Commission offered the prize, worth EUR2 million, to encourage inventors to overcome one of the biggest barriers to using vaccines in developing countries: the need to keep them stable at any ambient temperature.
Monday, March 10, 2014 — No Region Specified

India pledges new low-cost drugs to developing nations

Source: Zee News

Stressing that India's pharmaceutical technology was appropriate for Africa, Commerce Minister Anand Sharma said India is committed to making available to developing countries newer generation life-saving drugs also.
Thursday, March 6, 2014 — South Asia

U.S. Fears for Patents on Next-Generation Drugs in India

Source: The Chicago Tribune

An Indian committee is reviewing up to a dozen patented drugs to see if so-called compulsory licenses, which in effect break exclusivity rights, can be issued for some of them.
Wednesday, March 5, 2014 — No Region Specified

Serum Institute, Bilthovan to slash polio vaccine prices

Source: LiveMint

Pune-based Serum Institute of India Ltd and its Netherlands unit Bilthoven Biologicals BV on Tuesday announced about a 50% reduction in the price of their polio vaccines for the United Nation’s global polio eradication programme.
Tuesday, March 4, 2014 — Sub-Saharan Africa

Africa: Mobile Mast Vaccine Storage Project Wins Global Prize

Source: All Africa

An organisation that uses surplus energy from mobile phone masts to refrigerate vaccines in remote areas was named as the Best Mobile Health Product or Service at the Global Mobile Awards this week.
Monday, March 3, 2014 — No Region Specified

Indian drug firms may lose out as US pharma supply chain consolidates

Source: The Financial Express

Consolidation in the pharmaceuticals supply chain in the US will weigh on the bargaining power of Indian drug firms in that market, top Indian players apprehend. A spate of acquisitions and joint ventures — 16 in 2012 and 10 in 2013 — has resulted in fewer suppliers of prescription drugs, which might work against the interests of Indian firms.
Friday, February 28, 2014 — No Region Specified

Developing-World Disease Vaccines Being Prepared for Human Tests

Source: Science World Report

The fight against poverty-related diseases is gaining ground as scientists prepare trials of vaccines for hookworm, leishmaniasis and other parasitic diseases common in the developing world, thanks to the support of public research funding.
Friday, February 28, 2014 — No Region Specified

Developing-World Disease Vaccines Being Prepared for Human Tests

Source: Science World Report

The fight against poverty-related diseases is gaining ground as scientists prepare trials of vaccines for hookworm, leishmaniasis and other parasitic diseases common in the developing world, thanks to the support of public research funding.
Wednesday, February 26, 2014 — No Region Specified

Vaccines to be manufactured locally - President

Source: Business Ghana

Local pharmaceutical companies have benefited from Government funding amounting to Gh¢50 million to manufacture Anti-Retroviral Drugs (ARVs) in the country. This was announced by President John Mahama when he delivered the State of the Nation Address to Parliament on Tuesday.
Tuesday, February 25, 2014 — South Asia

Indian Medical Devices Industry Welcomes Changes in Bill

Source: The Health Site

The bill is significant because it recognises medical devices as distinct from pharmaceuticals for the first time and brings needed clarity to device regulation.
Wednesday, February 19, 2014 — No Region Specified

Vaccines endure African temperatures without damage

Source: Nature

An immunization campaign in West Africa has shown that vaccines can be delivered to remote areas without using ice boxes, and still remain viable. The finding challenges decades-old dogma that vaccines must be kept cool at every step of the chain from manufacture to use.
Monday, February 17, 2014 — No Region Specified

Solar vaccine fridge could save children

Source: Herald Scotland

Solar fridges could play a vital role in helping aid workers get life-saving vaccines to people in remote parts of developing countries, researchers say.
Monday, February 17, 2014 — No Region Specified

Africa Could Manufacture Its Own ARVs Drugs

Source: Spy Ghana

President John Dramani Mahama has made a strong case for African nations and other developing countries to be supported in the local manufacture of Anti Retroviral Drugs (ARV) to ensure a more affordable treatment of people living with AIDS.
Thursday, February 13, 2014 — South Asia

Merck Serono Supports India’s Two-tier Drug Pricing Policy

Source: The Economic Times

The US Chamber of Commerce may think India is an inhospitable terrain for innovation, but surprisingly, Big Pharma doesn't agree.
Thursday, February 13, 2014 — Sub-Saharan Africa

Merck expands its Capacity Advancement Campaign to Mozambique

Source: Africa Science News

Merck Germany has expanded the Capacity Advancement Program first rolled out in Kenya to Mozambique, a move to show its taking Africa seriously.
Friday, February 7, 2014 — No Region Specified

India is polio free, but faces threat of virus from Pakistan

Source: DNA India

India is all geared up to be tagged ‘polio-free,’ in February by the Indian Government after not a single case of polio was reported in the past three years within the country’s boundaries. At this juncture, World Health Organization (WHO) country head, Dr Nata Menabde speaks to Maitri Porecha and Santosh Andhale about the intricacies involved in tackling the crippling challenge of polio.
Thursday, February 6, 2014 — South Asia

Big pharma firms pushes for US action against India over patent worries

Source: The Economic Times

Global pharmaceutical firms are pressuring the United States to act against India to stop more local companies producing up to a dozen new varieties of cheap generic drugs still on-patent, sources with direct knowledge of the matter said.
Wednesday, February 5, 2014 — No Region Specified

Big pharma and healthcare providers join forces to promote wellbeing

Source: The Guardian

With cash-strapped healthcare systems around the world struggling, is it time to call on pharmaceutical companies for new innovation?
Tuesday, January 28, 2014 — No Region Specified

Janssen announces new group to tackle global health

Source: PM Live

Will implement R&D and access strategies to support areas with unmet public health need
Friday, January 24, 2014 — No Region Specified

Tuberculosis trial fails to aid S. African miners

Source: Capital News

What researchers described as a “radical” bid to cut down on tuberculosis among South African gold miners has failed to prevent infections or deaths, said a study out Wednesday.
Thursday, January 23, 2014 — No Region Specified

Janssen announces new group targeting unmet global health needs

Source: European Pharmaceutical Review

“To solve today’s greatest public health challenges, it’s essential that we emphasize the needs of the developing world in equal measure to those of the developed world,” said Paul Stoffels, M.D., Chief Scientific Officer, Johnson & Johnson and Worldwide Chairman of Janssen.
Wednesday, January 22, 2014 — No Region Specified

Kenya gets boost in the the fight against non-communicable diseases

Source: Africa Science News

The fight against non-communicable diseases in Kenya is set to go a notch higher with the decision by the Novartis Pharma of Switzerland to diversify its drug products portfolio n the Kenyan market.
Tuesday, January 21, 2014 — South Asia

Indian cos among emerging world's vaccine heroes: Bill Gates

Source: Business Standard

According to Gates, Serum Institute produces a higher volume of vaccines than any other company in the world
Monday, January 20, 2014 — No Region Specified

No pneumonia vaccines for Kampala

Source: The Observer

In an effort to protect infants from Pneumonia, the ministry of Health is rolling out administration of the Pneumococcal Conjugate Vaccine (PCV), starting this week.
Friday, January 17, 2014 — No Region Specified

New malaria discovery may lead to better vaccine and treatment

Source: Vaccine News Daily

Washington University School of Medicine said on Thursday that researchers have discovered how a form of malaria common in India, Southeast Asia and South America attacks blood cells.
Friday, January 17, 2014 — No Region Specified

Big pharma may threaten to cut South African investment in generics row

Source: Moneyweb

Global drug firms may threaten to cut their South African investments as part of a campaign against Pretoria's plans to overhaul its intellectual property laws to favour generic production, documents seen by Reuters show.
Thursday, January 16, 2014 — Sub-Saharan Africa

Better funding call for vital drug approval programme

Source: The Guardian

Without the prequalification programme of the World Health Organisation, Africa could have bad drugs or no drugs for HIV and TB, but this vital service for assessing medicine quality needs secure funds for the future, say experts
Wednesday, December 18, 2013 — No Region Specified

Schistosomiasis: a Latin American neglected tropical disease

Source: Saludify

Schistosomiasis is classified as a Latin American neglected tropical disease (NTD), meaning it belongs to a group of parasitic and bacterial diseases that cause substantial illness for more than one billion people globally, according to the Centers for Disease Control (CDC).
Monday, December 16, 2013 — No Region Specified

GSK bets on emerging markets with $1 billion plan to raise stake in India unit

Source: The West Australian

GlaxoSmithKline Plc (GSK) has decided to spend roughly $1 billion to raise its stake in its Indian pharmaceutical unit, betting on rising demand in emerging markets as sales in developed economies slow due to a wave of patent expirations.
Friday, December 13, 2013 — No Region Specified

Secretive US Trade Deal Could Endanger Global Health Gains

Source: Mintpress News

Much of the concern focuses on a host of provisions that would impact the ability of poor communities to get cheap generic medicines.
Tuesday, December 3, 2013 — Sub-Saharan Africa

How Africa's researchers are solving Africa's health problems

Source: The Guardian

Researchers are pioneering treatments on the continent, for health challenges unique to the continent – but despite the successes African research institutions continue to lag behind
Monday, November 25, 2013 — No Region Specified

GAVI Alliance to support introduction of inactivated polio vaccine in world’s 73 poorest countries

Source: GAVI Alliance

Alliance Board selects additional vaccines to include in its portfolio
Monday, November 25, 2013 — No Region Specified

The Gates Foundation’s Trevor Mundel on the Opposite of Rare Disease

Source: Xconomy

The foundation, started by a titan of capitalism, understands that if it’s going to make any kind of dent in huge health problems, it needs to tap into the resources of pharma and biotech
Thursday, October 31, 2013 — Sub-Saharan Africa

Strategic Alliance Formed to Fight Counterfeit Drugs in Ghana

Source: allAfrica

A new partnership will strengthen human resource capacity to conduct quality control testing to detect substandard and counterfeit medications in Africa.
Tuesday, October 15, 2013 — No Region Specified

Disrupting The Pharmaceutical Industry To Save The World From Diarrhea

Source: Ariel Schwartz, Co.Exist

Pharmaceutical companies like to focus on developing two kinds of drugs: blockbuster drugs that lots of people use (like Lipitor), and more recently, extremely expensive niche drugs. Drugs targeted specifically for common afflictions that affect the developing world aren't as profitable and are often left out of the picture entirely. Global health nonprofit Path is trying to change that with an ambitious drug development program that targets diseases like kala-azar (also known as black fever disease), malaria, HIV, and diarrheal diseases, such as cholera.
Wednesday, October 9, 2013 — Sub-Saharan Africa

Pharmaceutical firms profit from rising disease burden

Source: Business Day

A growing trend of ailments plaguing the Nigerian populace, including non-communicable diseases (NCDs) such as hypertension, cancer and diabetes, is offering huge growth prospects for pharmaceutical companies challenged to manufacture drugs to address the situation.
Tuesday, October 8, 2013 — No Region Specified

GSK aims to market world's first malaria vaccine

Source: The Baltimore Sun

British drugmaker GlaxoSmithKline will seek marketing approval for the world's first malaria vaccine next year after trial data showed the shot significantly cut cases of the disease in African children. The vaccine known as RTS,S was found, after 18 months of follow-up, to have almost halved the number of malaria cases in young children in the trial, and to have reduced by around a quarter the number of malaria cases in infants.
Friday, September 13, 2013 — Sub-Saharan Africa

Growing disease burden to drive pharma boom in Nigeria, Africa

Source: Business Day

Huge opportunities are in the offing for local drug manufacturers including Fidson Healthcare plc GlaxoSmithKline, Pfizer Nigeria and East Africa region (NEAR), Evans Medicals, Swipha, and Neimeth Pharmaceuticals, to grow their revenues on the back of recent surge in non-communicable diseases (NCDs).
Thursday, August 22, 2013 — Asia Pacific

Counterfeit medicine trade targets Africa's poor


"Street medication kills. The street is killing (safe) medication," declares a banner outside a pharmacy in the Cameroonian capital Yaounde, where the dangerous trade is rampant.
Wednesday, August 14, 2013 — South Asia

NCDs cost India equivalent to 12.5% of its GDP, says US-based study

Source: Pharmabiz

India, world’s largest generic medicines exporter, still lacks assured free access to good quality generic medicines and the support is needed to use them to best effect for large section of its population, says a study by US-based pharmacy school.
Wednesday, August 14, 2013 — No Region Specified

Increasing Profits by Reaching Pharma’s Silent Majority

Source: Pharma Evolution

We hear a lot in pharma about the voice of the customer, but the drug industry can’t hear the voices of millions of people around the world who might become its customers. Many die each year because they can’t afford to buy the medications they need to treat their illnesses.
Tuesday, August 13, 2013 — South Asia

Swati Piramal: How to Make India a World Leader in Low-Cost Health Care

Source: Forbes India

Bad regulations and price control are stifling pharma, but innovation in health care is blossoming with government support
Friday, August 9, 2013 — South Asia

India leads in supply of drugs to UN

Source: DNA

Affordable healthcare remains a distant reality inside the country.
Wednesday, August 7, 2013 — Asia Pacific

Taking the long view on Big Pharma in China

Source: The Globe and Mail

Big pharma’s Chinese dreams are bruised, but not broken.
Wednesday, July 31, 2013 — No Region Specified

Pfizer sells key vaccine cheaply to poor countries

Source: The Wall Street Journal

Drugmaker Pfizer Inc. has agreed to provide hundreds of millions of doses of its lucrative vaccine against pneumonia and meningitis at a fraction of the usual price for young children in poor countries.
Wednesday, July 17, 2013 — Asia Pacific

For Global Drug Manufacturers, China Becomes a Perilous Market

Source: The New York Times

Multinational drug companies now employ more sales agents in China than they do in the United States, their largest market.
Tuesday, July 9, 2013 — South Asia

Indian drug makers shifting R&D operations to South East Asia: Survey

Source: The Economic Times

AHMEDABAD: Red tapism is pushing India's Rs 1,00,000 crore pharmaceutical industry in peril as most of the pharma companies shifting research and development (R&D) operations and clinical trials to South-East Asian countries of Cambodia, Korea, Philippines, Singapore, Thailand, Vietnam and others, according to a just concluded survey by ASSOCHAM.
Tuesday, July 2, 2013 — Sub-Saharan Africa

Is Africa Profiting from Counterfeit Drugs?

Source: Spy Ghana

…penalties too low to stop crime
Friday, June 21, 2013 — No Region Specified

Let's set a global drug quality benchmark

Source: Business Today

The crisis in Indian pharma is a chance to develop a new regulatory path
Monday, June 17, 2013 — South Asia

Fake & sub-standard drugs: India, China may be worst offenders

Source: The Economic Times

The World Health Organisation (WHO) has a humble disclosure to make: there is still no accurate estimate of the global scale of counterfeit medicines.
Friday, June 14, 2013 — No Region Specified

U.S. top court bars patents on human genes unless synthetic

Source: Yahoo

A unanimous U.S. Supreme Court on Thursday prohibited patents on naturally occurring human genes but allowed legal protections on synthetically produced genetic material in a compromise ruling hailed as a partial victory for patients and the biotechnology industry.
Wednesday, June 12, 2013 — No Region Specified

India needs to show the world it respects intellectual property rights: Kiran Mazumdar-Shaw

Source: The Economic Times

India needs to show the world that it respects intellectual property rights if it wants global pharmaceutical firms to invest in India, according to Biocon Chairman and Managing Director Kiran Mazumdar-Shaw.
Friday, June 7, 2013 — No Region Specified

Renewed fight against fake drugs in Africa takes off

Source: The Guardian Nigeria

Worried by the dearth of experts and available tools to combat falsified, substandard and counterfeit medicines in countries in Sub-Saharan Africa including Nigeria, the United States Pharmacopeial Convention (USP) has launched the Center for Pharmaceutical Advancement and Training (CePAT) in Accra, Ghana.
Friday, June 7, 2013 — Asia Pacific

China's Healthcare Choice: Innovation or Access?

Source: Forbes

China today faces a dilemma in healthcare development between the present and the future. A fundamental choice will need to be made between financial incentives for future medical innovation or price controls that broaden present access to care
Wednesday, June 5, 2013 — No Region Specified

The battle for affordable drugs

Source: CNN World

“No intellectual property should stand in the way of you, the countries of the world, protecting your people. Do you agree or not?”
Monday, June 3, 2013 — No Region Specified

Will Hepatitis C Become A New Battleground Between Pharma And Poor Nations?

Source: Forbes

Will the new crop of hepatitis C treatments form the next battleground between the pharmaceutical industry, poor nations and patient advocates?
Wednesday, May 29, 2013 — Sub-Saharan Africa

Behind the Revolution of Diagnosis That Led to the HIV Miracle Baby...and More

Source: Huffington Post

"It's a revolution in diagnosis which is leading to a revolution in treatment," says Philippe Douste-Blazy of UNITAID.
Friday, May 17, 2013 — No Region Specified

How Drug Companies Keep Medicine Out of Reach

Source: The Atlantic

The promise of delinking research and development from the actual manufacture of drugs, and why the pharmaceutical industry rejects an idea that could turn neglected diseases into profit
Tuesday, February 5, 2013 — No Region Specified

Aid for vaccines is subsidising Big Pharma, doctors claim

Source: The Guardian

Médecins sans Frontières is concerned that immunization schemes in poor countries are unsustainable, and often unsuitable for hot climates.
Wednesday, January 30, 2013 — No Region Specified

Micro-Needles Could Allow Painless DNA Vaccines

Source: Live Science

Patches covered in microscopic needles could tattoo vaccines into the skin to boost a patient’s defense against disease, researchers say.
Tuesday, January 29, 2013 — No Region Specified

Glaxo Starts India Venture to Develop Emerging Market Vaccines


GlaxoSmithKline Plc (GSK) agreed to form a joint venture in India to produce a six-in-one vaccine that will immunize children in developing countries against infectious diseases including polio.
Monday, January 28, 2013 — No Region Specified

Antibiotic 'apocalypse' warning

Source: BBC

The rise in drug resistant infections is comparable to the threat of global warming, according to the chief medical officer for England.
Thursday, January 24, 2013 — No Region Specified

Billionaire Horse Breeder’s Polio Shot to Undercut Glaxo

Source: Bloomberg Businessweek

Indian billionaire Cyrus Poonawalla, founder of the world’s biggest maker of vaccines, will slash the price of polio immunization and introduce shots for diarrhea and pneumonia, undercutting Pfizer Inc. and GlaxoSmithKline.
Monday, January 14, 2013 — No Region Specified

UT Arlington receives Grand Challenges Explorations grant for research in global health


A new research grant could lead to new ways to cool vaccines and medicine that must be shipped to remote parts of the world without ready access to electricity.
Monday, January 7, 2013 — Sub-Saharan Africa

Drug-Resistant Malaria Flares As Funding For Research Tapers

Source: Think Progress

Global health experts worry that a new breed of malaria that has arisen in South Asia could reverse trends in the fight against the disease, since it has proven resistant to the drugs usually used to treat malaria infections.
Wednesday, January 2, 2013 — No Region Specified

First New TB Drug In 50 Years Approved Must Be Made Widely Available

Source: Doctors Without Borders

NEW YORK/GENEVA , December 31, 2012—The approval by the US Food and Drug Administration of an important new tuberculosis treatment must lead to its availability in countries with high levels of the drug-resistant form of the deadly disease
Thursday, December 20, 2012 — No Region Specified

Silk stabilizer could eliminate need to refrigerate vaccines

Source: Vaccine News Daily

Researchers at Tufts University recently found that a new silk-based stabilizer could get rid of the need to refrigerate vaccines and antibiotics, potentially enhancing vaccine delivery and storage in developing nations.
Tuesday, December 18, 2012 — No Region Specified

Vaccine Rule Is Said to Hurt Health Efforts

Source: New York Times

A group of prominent doctors and public health experts warns in articles to be published Monday in the journal Pediatrics that banning thimerosal, a mercury compound used as a preservative in vaccines, would devastate public health efforts in developing countries.
Thursday, December 13, 2012 — Sub-Saharan Africa

Saving Tanzania’s Poorest Children

Source: Inter Press Service

DAR ES SALAAM, Dec 13 2012 (IPS) - Half asleep, Anuary lies exhausted on his bed in Amana Hospital in Dar es Salaam, Tanzania’s capital. His mother, Mariam Saidi, sits on the edge of his mattress, staring blankly out of the window. Every now and then, she turns to wipe her 18-month-old son’s forehead.
Wednesday, December 12, 2012 — Sub-Saharan Africa

Nigeria: Global Fund Happy With HIV, TB Treatment in Nigeria

Source: All Africa

The Global Fund to fight AIDS, Tuberculosis and Malaria, on Tuesday expressed delight at the level of care and treatment given to persons infected with HIV and tuberculosis in Nigeria.
Wednesday, December 12, 2012 — Sub-Saharan Africa

Tanzania free of tetanus in mothers and babies

Source: Saudi Gazette

Dar Essalam —The Tanzanian government yesterday celebrated the introduction of two vaccines to protect children against pneumonia and diarrhea and announced that it has been declared free of maternal and neonatal tetanus (MNT), one of the world’s major causes of deaths in mothers and newborns.
Tuesday, December 11, 2012 — Sub-Saharan Africa

GSK Forms Partnership with Vodafone to Help Increase Childhood Vaccination in Mozambique


GSK today announced it has formed a partnership with Vodafone to harness innovative mobile technology to help vaccinate more children against common infectious diseases in Africa. Despite major advances in the funding and availability of vaccines worldwide, it is estimated that up to a fifth of children worldwide still do not receive basic vaccines. The proliferation of mobile phones in Africa offers an opportunity to create innovative and cost-effective ways to address barriers to universal vaccination.
Thursday, December 6, 2012 — Sub-Saharan Africa

GAVI Needs to Offer Lower Vaccine Prices to Humanitarian Groups

Source: Doctors Without Borders

DAR ES SALAAM/GENEVA, DECEMBER 5, 2012—The GAVI Alliance should systematically extend the discounted vaccine prices it obtains from pharmaceutical companies to humanitarian organizations that are often well placed to reach unvaccinated children, the international medical humanitarian organization Doctors Without Borders/Médecins Sans Frontières (MSF) said today at the GAVI Partners Forum meeting in Tanzania.
Tuesday, December 4, 2012 — South Asia

Sanofi shakes up diabetes market in India

Source: LiveMint

The firm is changing the rules of the game by is lowering prices, localizing products for treatment of the disease
Tuesday, December 4, 2012 — Sub-Saharan Africa

Nigeria: MSD Introduces New HIV Drug, Atripla

Source: All Africa

AS part of the efforts to meet the Anti-Retroviral, ARV, drugs requirements of Nigerians living with HIV, MSD, one of the world’s healthcare leaders, weekend launched into the Nigerian market its innovative antiretroviral, ARV, drug – Atripla – a prescription medication used to treat HIV-1 infection in adults and children of at least 12 years of age.
Thursday, October 11, 2012 — Europe & Eurasia

GlaxoSmithKline opens door on data in bid to aid discovery of medicines

Source: The Guardian

British drugs company releases findings of clinical trials and announces new effort to find tropical disease cures
Friday, February 10, 2012 — Sub-Saharan Africa

Benin Makes Headway in Attempt to Reduce Deaths from Malaria

Source: The Guardian

Last year Benin announced free treatment for malaria, and has now followed up by cracking down on fake drugs and recruiting an army of outreach health workers
Wednesday, February 1, 2012 — No Region Specified

GSK's Andrew Witty on the Future of Pharma Collaboration to Help Poor Countries

Source: The Guardian

Just before the all-singing, all-dancing launch of the big initiative to control or eliminate 10 neglected diseases – starring 13 CEOs from Big Pharma, the WHO's director general, Margaret Chan, and Bill Gates – I grabbed a few words with Sir Andrew Witty, head of GlaxoSmithKline, who co-chaired the negotiations over the past year with Gates.
Monday, March 21, 2011 — Latin America

PepsiCo Foundation Announces $5 M Grant to IDB's AquaFund

Source: Microfinance Focus

The PepsiCo Foundation recently announced a $5 million grant to the AquaFund, launched by the Inter-American Development Bank (IDB), to facilitate investment in water supply and sanitation, water resources, solid waste management and wastewater treatment. The AquaFund agreement was signed by Luis Montoya, President of PepsiCo Latin American Beverages, and Luis Alberto Moreno, President of the IDB, at the International Environment Summit in Guayaquil, Ecuador. The grant will fund a...
  • Managing Partners

    William Davidson Institute
  • Sponsoring Partner

    Citi Foundation
  • Content Partners

Subscribe to Our E-Newsletter

For Email Marketing you can trust

Found an Article we're Missing?Found an Article we're Missing?

Submit An Article


Social MediaSocial Media

Facebook Twitter

Story Snapshot